SALKIND GENE purchased 125K shares of UPEXI, INC. on the open market
Open‑market purchase worth $500.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/1/2022ACC: 0001477932-22-001943
Director10% Owner
+125K
Net shares
Net buyer
$500.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
125K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+125K
Price / share
$4.00
Trade value
$500K
% of position
New position
—
0.00→125K
Total
Net shares
+125K
Net value
$500K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | — | P · Purchase | +125K | $4.00 | $500K | New position | 0.00 | 125K |
| Total | +125K | $500K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned2.35M
Total
2.35M direct2.35M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.35M | Direct |
| Total | 2.35M | 2.35M direct |
Derivative Holdings (Post-Transaction)2
Option Grant
DirectUnderlying security
Common
Underlying shares
27.78K
Shares owned
27.78K
Exercise price
1.53
Expiration
—
Exercise window
—
Option Grant
DirectUnderlying security
Common
Underlying shares
50K
Shares owned
50K
Exercise price
4.18
Expiration
—
Exercise window
—
Total
Underlying
77.78K
Owned
77.78K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Option Grant Direct | Common | 1.53 | — | — | 27.78K | 27.78K |
| Option Grant Direct | Common | 4.18 | — | — | 50K | 50K |
| Total | 77.78K | 77.78K | ||||